Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Petadolex

This article was originally published in The Tan Sheet

Executive Summary

Botanical migraine formula containing butterbur root extract "significantly reduced the frequency of migraine attacks and days with migraine per month as well as the frequency of accompanying symptoms" compared to placebo, write Alexander Mauskop, MD, New York Headache Center, et al,. in the May issue of Headache: The Journal of Head and Face Pain. Clinical trials of the product underway at four U.S. sites and six European sites will encompass a total of 245 subjects. German pharmaceutical firm Weber & Weber sells the supplement in the U.S. through pharmacies, health food stores and the company's Web site (www.migraineaid.com)
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091493

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel